ACL — Australian Clinical Labs Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapContrarian

Annual balance sheet for Australian Clinical Labs, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	R2021 June 30th	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	36.3	27.5	20.6	26.8	22.1
Net Total Accounts Receivable
Net Total Receivables	63	91.1	75	81.4	72.8
Total Inventory
Prepaid Expenses
Total Current Assets	117	143	116	134	120
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	238	310	288	282	270
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	484	628	579	593	575
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	166	225	188	208	216
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	402	396	406	416	403
Common Stock
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	81.9	232	172	178	171
Total Liabilities & Shareholders' Equity	484	628	579	593	575
Total Common Shares Outstanding